Imaging in Parkinson's disease

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 16, Issue 4, 2016, Pages 371-375

  Pagano, Gennaro ^a   Niccolini, Flavia ^a   Politis, Marios ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

DaTSCAN ; FDG; Imaging; MIBG; MRI; Parkinson's; PET; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; FLUORODEOXYGLUCOSE F 18; IOFLUPANE I 123;

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE COURSE; ESSENTIAL TREMOR; EVIDENCE BASED MEDICINE; FUNCTIONAL NEUROIMAGING; HUMAN; IN VIVO STUDY; MOLECULAR IMAGING; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; DIAGNOSTIC IMAGING; PATHOLOGY; PATHOPHYSIOLOGY;

BRAIN; HUMANS; MOLECULAR IMAGING; NEUROIMAGING; PARKINSON DISEASE;

EID: 85015349159     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.16-4-371     Document Type: Article

References (22)

1. Politis M. Neuroimaging in Parkinson disease: from research setting to clinical practice. Nat Rev Neurol 2014;10:708-22.
2. Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010;25:1646-51.
3. Politis M, Wu K, Loane C et al. Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 2010;75:1920-7.
4. Politis M, Loane C, Wu K, Brooks DJ, Piccini P. Serotonergic mediated body mass index changes in Parkinson's disease. Neurobiol Dis 2011;43:609-15.
5. Righini A, Antonini A, Ferrarini M et al. Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr 2002;26:266-71.
6. ∗-weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002;59:1265-7.
7. Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC. Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005;64:675-9.
8. Cordato NJ, Pantelis C, Halliday GM et al. Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 2002;125:789-800.
9. Schocke MF, Seppi K, Esterhammer R et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002;58:575-80.
10. Planetta PJ, Ofori E, Pasternak O et al. Free-water imaging in Parkinson's disease and atypical Parkinsonism. Brain 2016; 139: 495-508.
11. Weiduschat N, Mao X, Beal MF et al. Usefulness of proton and phosphorus MR spectroscopic imaging for early diagnosis of Parkinson's disease. J Neuroimaging 2015;25:105-10.
12. Al-Bachari S, Parkes LM, Vidyasagar R et al. Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease. Neuroimage Clin 2014;6:1-8.
13. Wu T, Ma Y, Zheng Z et al. Parkinson's disease-related spatial covariance pattern identified with resting-state functional MRI. J Cereb Blood Flow Metab 2015; 35: 1764-70.
14. Benamer TS, Patterson J, Grosset DG et al. Accurate differentiation of Parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503-10.
15. Benamer HT, Oertel WH, Patterson J et al. Prospective study of presynaptic dopaminergic imaging in patients with mild Parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord 2003;18:977-84.
16. Asenbaum S, Pirker W, Angelberger P et al. [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease. J Neural Transm (Vienna) 1998;105:1213-28.
17. Jennings DL, Seibyl JP, Oakes D et al. (123I) beta-CIT and singlephoton emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 2004;61:1224-9.
18. Orimo S, Suzuki M, Inaba A, Mizusawa H. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative Parkinsonism: a systematic review and meta-analysis. Parkinsonism Relat Disord 2012;18:494-500.
19. Tang CC, Poston KL, Eckert T et al. Differential diagnosis of Parkinsonism: a metabolic imaging study using pattern analysis. Lancet Neurol 2010;9:149-58.
20. Gerhard A, Pavese N, Hotton G et al. In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease. Neurobiol Dis 2006;21:404-12.
21. Niccolini F, Foltynie T, Reis Marques T et al. Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease. Brain 2015;138:3003-15.
22. Politis M, Wu K, Loane C et al. Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients. J Clin Invest 2014;124:1340-9.